Please contact our sales representative to learn more information about this reagents.
Background
Etaracizumab, also known as etaratuzumab, [citation needed] MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune.